Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06356272
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-04-04
Brief Title:
Oropharynx OPX Biomarker Trial
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Oropharynx OPX Biomarker Trial
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to identify a biomarker that is exists when human papillomavirus HPV mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent
Detailed Description:
PRIMARY OBJECTIVE
I To identify a biomarker or biomarkers that is present when disease is present ie at diagnosis or recurrence and not present when disease is absent ie after treatment in HPV negative patients or in normal controls
OUTLINE This is an observational study
Patients undergo blood sample collection saliva sample collection complete questionnaires and have their medical records reviewed on study
I To identify a biomarker or biomarkers that is present when disease is present ie at diagnosis or recurrence and not present when disease is absent ie after treatment in HPV negative patients or in normal controls
OUTLINE This is an observational study
Patients undergo blood sample collection saliva sample collection complete questionnaires and have their medical records reviewed on study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-00965 | REGISTRY | None | None |
| 19-006036 | OTHER | Mayo Clinic Institutional Review Board | None |